2022-04-012023-03-312023-03-31false13302675ASR DENTAL CARE HACKENTHORPE LIMITED2023-12-15iso4217:GBPxbrli:pure133026752022-04-01133026752023-03-31133026752022-04-012023-03-31133026752021-03-30133026752022-03-31133026752021-03-302022-03-3113302675bus:SmallEntities2022-04-012023-03-3113302675bus:AuditExempt-NoAccountantsReport2022-04-012023-03-3113302675bus:FullAccounts2022-04-012023-03-3113302675bus:PrivateLimitedCompanyLtd2022-04-012023-03-3113302675core:WithinOneYear2023-03-3113302675core:AfterOneYear2023-03-3113302675core:WithinOneYear2022-03-3113302675core:AfterOneYear2022-03-3113302675core:ShareCapital2023-03-3113302675core:SharePremium2023-03-3113302675core:RevaluationReserve2023-03-3113302675core:OtherReservesSubtotal2023-03-3113302675core:RetainedEarningsAccumulatedLosses2023-03-3113302675core:ShareCapital2022-03-3113302675core:SharePremium2022-03-3113302675core:RevaluationReserve2022-03-3113302675core:OtherReservesSubtotal2022-03-3113302675core:RetainedEarningsAccumulatedLosses2022-03-3113302675core:LandBuildings2023-03-3113302675core:PlantMachinery2023-03-3113302675core:Vehicles2023-03-3113302675core:FurnitureFittings2023-03-3113302675core:OfficeEquipment2023-03-3113302675core:NetGoodwill2023-03-3113302675core:IntangibleAssetsOtherThanGoodwill2023-03-3113302675core:ListedExchangeTraded2023-03-3113302675core:UnlistedNon-exchangeTraded2023-03-3113302675core:LandBuildings2022-03-3113302675core:PlantMachinery2022-03-3113302675core:Vehicles2022-03-3113302675core:FurnitureFittings2022-03-3113302675core:OfficeEquipment2022-03-3113302675core:NetGoodwill2022-03-3113302675core:IntangibleAssetsOtherThanGoodwill2022-03-3113302675core:ListedExchangeTraded2022-03-3113302675core:UnlistedNon-exchangeTraded2022-03-3113302675core:LandBuildings2022-04-012023-03-3113302675core:PlantMachinery2022-04-012023-03-3113302675core:Vehicles2022-04-012023-03-3113302675core:FurnitureFittings2022-04-012023-03-3113302675core:OfficeEquipment2022-04-012023-03-3113302675core:NetGoodwill2022-04-012023-03-3113302675core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3113302675core:ListedExchangeTraded2022-04-012023-03-3113302675core:UnlistedNon-exchangeTraded2022-04-012023-03-3113302675core:MoreThanFiveYears2022-04-012023-03-3113302675core:Non-currentFinancialInstruments2023-03-3113302675core:Non-currentFinancialInstruments2022-03-3113302675dpl:CostSales2022-04-012023-03-3113302675dpl:DistributionCosts2022-04-012023-03-3113302675core:LandBuildings2022-04-012023-03-3113302675core:PlantMachinery2022-04-012023-03-3113302675core:Vehicles2022-04-012023-03-3113302675core:FurnitureFittings2022-04-012023-03-3113302675core:OfficeEquipment2022-04-012023-03-3113302675dpl:AdministrativeExpenses2022-04-012023-03-3113302675core:NetGoodwill2022-04-012023-03-3113302675core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3113302675dpl:GroupUndertakings2022-04-012023-03-3113302675dpl:ParticipatingInterests2022-04-012023-03-3113302675dpl:GroupUndertakingscore:ListedExchangeTraded2022-04-012023-03-3113302675core:ListedExchangeTraded2022-04-012023-03-3113302675dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-04-012023-03-3113302675core:UnlistedNon-exchangeTraded2022-04-012023-03-3113302675dpl:CostSales2021-03-302022-03-3113302675dpl:DistributionCosts2021-03-302022-03-3113302675core:LandBuildings2021-03-302022-03-3113302675core:PlantMachinery2021-03-302022-03-3113302675core:Vehicles2021-03-302022-03-3113302675core:FurnitureFittings2021-03-302022-03-3113302675core:OfficeEquipment2021-03-302022-03-3113302675dpl:AdministrativeExpenses2021-03-302022-03-3113302675core:NetGoodwill2021-03-302022-03-3113302675core:IntangibleAssetsOtherThanGoodwill2021-03-302022-03-3113302675dpl:GroupUndertakings2021-03-302022-03-3113302675dpl:ParticipatingInterests2021-03-302022-03-3113302675dpl:GroupUndertakingscore:ListedExchangeTraded2021-03-302022-03-3113302675core:ListedExchangeTraded2021-03-302022-03-3113302675dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-03-302022-03-3113302675core:UnlistedNon-exchangeTraded2021-03-302022-03-3113302675core:NetGoodwill2023-03-3113302675core:IntangibleAssetsOtherThanGoodwill2023-03-3113302675core:LandBuildings2023-03-3113302675core:PlantMachinery2023-03-3113302675core:Vehicles2023-03-3113302675core:FurnitureFittings2023-03-3113302675core:OfficeEquipment2023-03-3113302675core:AfterOneYear2023-03-3113302675core:WithinOneYear2023-03-3113302675core:ListedExchangeTraded2023-03-3113302675core:UnlistedNon-exchangeTraded2023-03-3113302675core:ShareCapital2023-03-3113302675core:SharePremium2023-03-3113302675core:RevaluationReserve2023-03-3113302675core:OtherReservesSubtotal2023-03-3113302675core:RetainedEarningsAccumulatedLosses2023-03-3113302675core:NetGoodwill2022-03-3113302675core:IntangibleAssetsOtherThanGoodwill2022-03-3113302675core:LandBuildings2022-03-3113302675core:PlantMachinery2022-03-3113302675core:Vehicles2022-03-3113302675core:FurnitureFittings2022-03-3113302675core:OfficeEquipment2022-03-3113302675core:AfterOneYear2022-03-3113302675core:WithinOneYear2022-03-3113302675core:ListedExchangeTraded2022-03-3113302675core:UnlistedNon-exchangeTraded2022-03-3113302675core:ShareCapital2022-03-3113302675core:SharePremium2022-03-3113302675core:RevaluationReserve2022-03-3113302675core:OtherReservesSubtotal2022-03-3113302675core:RetainedEarningsAccumulatedLosses2022-03-3113302675core:NetGoodwill2021-03-3013302675core:IntangibleAssetsOtherThanGoodwill2021-03-3013302675core:LandBuildings2021-03-3013302675core:PlantMachinery2021-03-3013302675core:Vehicles2021-03-3013302675core:FurnitureFittings2021-03-3013302675core:OfficeEquipment2021-03-3013302675core:AfterOneYear2021-03-3013302675core:WithinOneYear2021-03-3013302675core:ListedExchangeTraded2021-03-3013302675core:UnlistedNon-exchangeTraded2021-03-3013302675core:ShareCapital2021-03-3013302675core:SharePremium2021-03-3013302675core:RevaluationReserve2021-03-3013302675core:OtherReservesSubtotal2021-03-3013302675core:RetainedEarningsAccumulatedLosses2021-03-3013302675core:AfterOneYear2022-04-012023-03-3113302675core:WithinOneYear2022-04-012023-03-3113302675core:Non-currentFinancialInstrumentscore:CostValuation2022-04-012023-03-3113302675core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-04-012023-03-3113302675core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-04-012023-03-3113302675core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-04-012023-03-3113302675core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-04-012023-03-3113302675core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-04-012023-03-3113302675core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3113302675core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3113302675core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3113302675core:Non-currentFinancialInstrumentscore:CostValuation2023-03-3113302675core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-3113302675core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-3113302675core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-3113302675core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-3113302675core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-3113302675core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-3113302675core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-3113302675core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-3113302675core:Non-currentFinancialInstrumentscore:CostValuation2022-03-3113302675core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-03-3113302675core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-03-3113302675core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-03-3113302675core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-03-3113302675core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-03-3113302675core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-03-3113302675core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-03-3113302675core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-03-3113302675bus:Director12022-04-012023-03-31

ASR DENTAL CARE HACKENTHORPE LIMITED

Registered Number
13302675
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2023

ASR DENTAL CARE HACKENTHORPE LIMITED
Company Information
for the year from 1 April 2022 to 31 March 2023

Director

HUSSAIN, Altaf, Dr

Registered Address

The Crescent Dental & Implant Centre Asr Finance Office
The Crescent
Selby
YO8 4PE

Registered Number

13302675 (England and Wales)
ASR DENTAL CARE HACKENTHORPE LIMITED
Statement of Financial Position
31 March 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Intangible assets6194,216-
194,216-
Current assets
Debtors84,102100
Cash at bank and on hand22,928-
27,030100
Creditors amounts falling due within one year9(61,778)-
Net current assets (liabilities)(34,748)100
Total assets less current liabilities159,468100
Creditors amounts falling due after one year10(166,772)-
Net assets(7,304)100
Capital and reserves
Called up share capital100100
Profit and loss account(7,404)-
Shareholders' funds(7,304)100
The financial statements were approved and authorised for issue by the Director on 15 December 2023, and are signed on its behalf by:
HUSSAIN, Altaf, Dr
Director
Registered Company No. 13302675
ASR DENTAL CARE HACKENTHORPE LIMITED
Notes to the Financial Statements
for the year ended 31 March 2023

1.Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
2.Compliance with applicable reporting framework
These financial statements have been prepared in compliance with FRS 102 Section 1A, The Financial Reporting Standard applicable in the UK and Republic of Ireland.
3.Principal activities
The principal activity of the company during the year was that of a dental practice.
4.Accounting policies
Intangible assets policy
Intangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated amortisation and impairment losses. Any intangible assets carried at revalued amounts, are recorded at the fair value at the date of revaluation, as determined by reference to an active market, less any subsequent accumulated amortisation and subsequent accumulated impairment losses. Intangible assets acquired as part of a business combination are only recognised separately from goodwill when they arise from contractual or other legal rights, are separable, the expected future economic benefits are probable and the cost or value can be measured reliably.
Employee benefits policy
Contributions to defined contribution plans are expensed in the period to which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
Going concern
Following the challenges arising as a consequence of the Covid-19 pandemic in 2020/21, more latterly the UK economy has been impacted by rising inflation, interest rates and energy costs, exacerbated by the war in Ukraine. All these matters have impacted the company’s trading results to a greater or lesser extent. At the date of signing these financial statements, the directors have considered the effect of these matters on the company with the information available to it, and do not believe that it will affect the ability of the company to continue to trade for the foreseeable future. On this basis, the directors have prepared these financial statements on a going concern basis.
5.Employee information

20232022
Average number of employees during the year90
6.Intangible assets

Goodwill

Total

££
Cost or valuation
Additions194,216194,216
At 31 March 23194,216194,216
Net book value
At 31 March 23194,216194,216
At 31 March 22--
7.Property, plant and equipment
8.Debtors

2023

2022

££
Trade debtors / trade receivables3,934-
Amounts owed by associates and joint ventures / participating interests-100
Other debtors47-
Prepayments and accrued income121-
Total4,102100
9.Creditors within one year

2023

2022

££
Trade creditors / trade payables16,531-
Bank borrowings and overdrafts19,165-
Amounts owed to related parties9,480-
Other creditors13,601-
Accrued liabilities and deferred income3,001-
Total61,778-
10.Creditors after one year

2023

2022

££
Bank borrowings and overdrafts166,772-
Total166,772-